A Review of Clinical and Laboratory Predictors of Severe COVID-19 Disease

References

1. 1.↵
   1. Wu Z,
   2. McGoogan J

   . Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China. summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lake M

   . What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 2020;20:124–7.

   OpenUrl
3. 3.↵
   1. Singhal T

   . A review of Coronavirus disease-2019. Indian J Pediatr 2020;87:281–6.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Mo P,
   2. Xing Y,
   3. Xiao Y,
   4. et al

   . Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020 Mar 16, ciaa270.
5. 5.↵
   1. Leung C

   . Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol 2020;30:e2103.

   OpenUrlPubMed
6. 6.↵
   1. Wu C,
   2. Chen X,
   3. Cai Y,
   4. et al

   . Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan. JAMA Intern Med 2020;180:934–43.

   OpenUrlPubMed
7. 7.↵
   1. Zhou F,
   2. Yu T,
   3. Du R,
   4. et al

   . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Zhang J,
   2. Dong X,
   3. Cao Y-Y,
   4. et al

   . Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730–41.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Du R-H,
   2. Liang L-R,
   3. Yang C-Q,
   4. et al

   . Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 2020;55:2000524.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Li K,
    2. Chen D,
    3. Chen S,
    4. et al

    . Predictors of fatality including radiographic findings in adults with COVID-19. Respir Res 2020;21:146.

    OpenUrl
11. 11.↵
    1. Nascimento I,
    2. Cacic N,
    3. Abdulazeem HA,
    4. et al

    . Novel Coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med 2020;9:941.

    OpenUrl
12. 12.↵
    1. Ruan Q,
    2. Yang K,
    3. Wang W,
    4. et al

    . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–8.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Ruan S

    . Likelihood of survival of coronavirus disease 2019. Lancet Infect Dis 2020;20:630–1.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Yang J,
    2. Zheng Y,
    3. Gou X,
    4. et al

    . Prevalence of co-morbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–5.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Yan L,
    2. Zhang H-T,
    3. Gonclaves J,
    4. et al

    . An interpretable mortality prediction model for COVID-19 patients. Nature Machine Intelligence 2020;2:283–8.

    OpenUrl
16. 16.↵
    1. Tan L,
    2. Wang Q,
    3. Zhang D,
    4. et al

    . Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Sig Transduct Target Ther 2020;5:33.

    OpenUrl
17. 17.↵
    1. Brass D,
    2. McKay P,
    3. Scott F

    . Investigating an incidental finding of lymphopenia. BMJ 2014;348:g1721.

    OpenUrlFREE Full Text
18. 18.↵
    1. Poggiali E,
    2. Zaino D,
    3. Immovilli P,
    4. et al

    . Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clin Chim Acta 2020;509:135–8.

    OpenUrlCrossRef
19. 19.↵
    1. Sarzi-Puttini P,
    2. Giorgi V,
    3. Sirotti S,
    4. et al

    . COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 2020;38:337–42.

    OpenUrlPubMed
20. 20.↵
    1. Galli C,
    2. Plebani M

    . Clinical laboratory and SARS-CoV-2 infection: where do we stand? Clin Chem Lab Med 2020;58:1139–41.

    OpenUrl
21. 21.↵
    1. Lippi G,
    2. Plebani M

    . Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 2020;505:190–1.

    OpenUrlCrossRefPubMed